XENETIC BIOSCIENCES, INC. — Net Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/094d0f2e-abb2-474a-bba0-2152f4902667/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-2.7M | 2025-01-01 – 2025-12-31 | evidence 0001683168-26-001737 |
| FY 2024 | $-4.0M | 2024-01-01 – 2024-12-31 | evidence 0001683168-25-001686 |
| FY 2023 | $-4.1M | 2023-01-01 – 2023-12-31 | evidence 0001683168-24-001594 |
| FY 2022 | $-6.6M | 2022-01-01 – 2022-12-31 | evidence 0001683168-23-001674 |
| FY 2021 | $-5.6M | 2021-01-01 – 2021-12-31 | evidence 0001683168-22-001839 |
| FY 2020 | $-10.9M | 2020-01-01 – 2020-12-31 | evidence 0001683168-21-000969 |
| FY 2019 | $-12.8M | 2019-01-01 – 2019-12-31 | evidence 0001683168-20-000967 |
| FY 2018 | $-7.3M | 2018-01-01 – 2018-12-31 | evidence 0001683168-19-000840 |
| FY 2017 | $-3.6M | 2017-01-01 – 2017-12-31 | evidence 0001683168-18-000831 |
| FY 2016 | $-54.2M | 2016-01-01 – 2016-12-31 | evidence 0001683168-17-000749 |
| FY 2015 | $-12.5M | 2015-01-01 – 2015-12-31 | evidence 0001019687-16-005662 |
| FY 2014 | $-14.3M | 2014-01-01 – 2014-12-31 | evidence 0001019687-15-001465 |
| FY 2013 | $-8.6M | 2013-01-01 – 2013-12-31 | evidence 0001019687-15-001465 |
| FY 2012 | $-151.0k | 2011-08-09 – 2013-05-31 | evidence 0001255294-13-000560 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
XENETIC BIOSCIENCES, INC. — all facts · Revenue · Operating Income